Creative Commons source reading · Multiple sclerosis and neuroimmunology
Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica.
Robert Wilson; Mateusz Makuch; Anne-Kathrin Kienzler; James Varley; Jennifer Taylor; Mark Woodhall; Jacqueline Palace; M Isabel Leite; Patrick Waters; Sarosh R Irani
Originally published in Brain : a journal of neurology · 2018-04-01
From the article
Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.
Abstract
Autoantibodies to aquaporin-4 (AQP4) are pathogenic in neuromyelitis optica spectrum disorder (NMOSD). However, it is not known which B cells are the major contributors to circulating AQP4 antibodies nor which conditions promote their generation. Our experiments showed CD19+CD27++CD38++ circulating ex vivo antibody-secreting cells did not produce AQP4 antibodies under several culture conditions. To question whether other cells in circulation were capable of AQP4 antibody production, B cells were differentiated into antibody-secreting cells in vitro. Unfractionated peripheral blood mononuclear cells, isolated from 12 patients with NMOSD and a wide range of serum AQP4 antibody levels (91-26 610 units), were cultured with factors that mimicked established associations of NMOSD including T cell help, concurrent infections and cytokines reported to be elevated in NMOSD. Overall, the in vitro generation of CD19+CD27++CD38++ cells across several culture conditions correlated closely with the total IgG secreted (P < 0.0001, r = 0.71), but not the amount of AQP4 antibody.
Discussion
This study established a multiparameter in vitro human culture system to characterize the contribution of peripheral B cells to the production of serum AQP4-IgGs, and generated several novel insights. First, circulating B cells differentiated in vitro and were able to produce AQP4-IgGs in the absence of antigen. The factors that induced AQP4-IgGs did so from unfractionated PBMC cultures at physiological concentrations without complex cytokine combinations.
Editorial reading guide
- Which patient population and reference standard did the authors use?
- Was the finding validated in a separate cohort, and how might patient selection affect it?
